Metformin Hydrochloride Market

Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5?HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform.
In Metformin Hydrochloride Market , our statistics is given by metformin hydrochloride API.
Metformin Hydrochloride Market aims to provide a comprehensive presentation of the global market for Metformin Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metformin Hydrochloride. Metformin Hydrochloride Market contains market size and forecasts of Metformin Hydrochloride in global, including the following market information:
Global Metformin Hydrochloride Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Metformin Hydrochloride Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Metformin Hydrochloride companies in 2022 (%)
The global Metformin Hydrochloride market was valued at US$ 265 million in 2022 and is projected to reach US$ 346.9 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Asia-Pacific is the largest market with about 60% revenue market share. Followed by Europe, accounting for about 17% revenue market share.
The key players are Wanbury, USV, Exemed Pharmaceuticals, Vistin Pharma, Aarti Drugs, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Keyuan Pharmaceutical, CR Double-Crane, Shouguang Fukang Pharmaceutical etc. USV is the largest manufacturer with about 26% revenue market share.
We surveyed the Metformin Hydrochloride manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metformin Hydrochloride Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Metformin Hydrochloride Market Segment Percentages, by Type, 2022 (%)
Metformin HCL
Metformin DC
Others
Global Metformin Hydrochloride Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Metformin Hydrochloride Market Segment Percentages, by Application, 2022 (%)
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others
Global Metformin Hydrochloride Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Metformin Hydrochloride Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metformin Hydrochloride revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Metformin Hydrochloride revenues share in global market, 2022 (%)
Key companies Metformin Hydrochloride sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Metformin Hydrochloride sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Wanbury
USV
Exemed Pharmaceuticals
Vistin Pharma
Aarti Drugs
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Keyuan Pharmaceutical
CR Double-Crane
Shouguang Fukang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metformin Hydrochloride, market overview.
Chapter 2: Global Metformin Hydrochloride market size in revenue and volume.
Chapter 3: Detailed analysis of Metformin Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metformin Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Metformin Hydrochloride capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.